Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aventis’ Estorra Rights Acquired By Private Equity Firm In $115 Mil. Deal

Executive Summary

The Paul Royalty Fund II will purchase Aventis' U.S. rights for Estorra for $115 mil., the private equity firm announced Aug. 9

You may also be interested in...



Lunesta Clears FDA; Sepracor Plans 2005 Release Of Depression Data

Sepracor plans to present data from its completed Lunesta (eszopiclone) Phase IIIb/IV trial for the treatment of insomnia in patients suffering from depression in 2005

Lunesta Clears FDA; Sepracor Plans 2005 Release Of Depression Data

Sepracor plans to present data from its completed Lunesta (eszopiclone) Phase IIIb/IV trial for the treatment of insomnia in patients suffering from depression in 2005

Sanofi-Aventis Begins Operations; Markham, Senior Aventis Execs Depart

Sanofi-Aventis is beginning operations as a top 10 pharmaceutical company in the U.S

Related Content

Topics

UsernamePublicRestriction

Register

PS044491

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel